<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00758407</url>
  </required_header>
  <id_info>
    <org_study_id>6520-9959-02</org_study_id>
    <nct_id>NCT00758407</nct_id>
  </id_info>
  <brief_title>Methylphenidate Treatment of Cancer-Related Fatigue</brief_title>
  <acronym>EMF</acronym>
  <official_title>Placebo Controlled Double Blind Study With Methylphenidate in Treatment of Adults With Cancer-Related Fatigue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medice Arzneimittel Pütter GmbH &amp; Co KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medice Arzneimittel Pütter GmbH &amp; Co KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized controlled clinical trial is to investigate the efficacy and
      safety of methylphenidate in patients with fatigue caused by cancer.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>General Fatigue measured by the Multidimensional Fatigue Inventory (Subscale General Fatigue)</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (EORTC-QLQ C30)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Cancer-related Fatigue</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylphenidate hydrochloride</intervention_name>
    <description>sustained release, dosage according to an individual titration schedule</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>dosage according to an individual titration schedule</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  history of Cancer

          -  MFI &gt;40

          -  Karnofsky Index &gt;=70

          -  outpatient

          -  patient are able to give informed consent

        Exclusion Criteria:

          -  treatment with psychostimulants in the past two weeks before screening

          -  active tumor disease

          -  depression (HADS &gt;10)

          -  cachexia (BMI &lt;18kg/m2)

          -  clinically relevant kidney disorders

          -  clinically relevant liver disorder

          -  pathological ECG-finding

          -  high blood pressure

          -  occlusive arterial disease

          -  angina pectoris

          -  cardiac arrhythmias

          -  CHD

          -  post heart-attack status

          -  post stroke status

          -  known elevated intra-ocular pressure

          -  known enlarged prostates

          -  latent and manifest hyperthyreosis

          -  alcohol, medication or drug dependency in the past six months or manifest drug abuse

          -  participation in a clinical study within the past 30 days

          -  participation in this study at an earlier point in time

          -  simultaneous participation in another clinical trial

          -  women of child-bearing age without adequate contraception (contraceptives,
             intrauterine device , no sexual intercourse)

          -  pregnancy (positive pregnancy test) or lactation period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manfred Heim, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sonnenbergklinik, Hardstr. 13, D-37242 Bad Sooden-Allendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sonnenbergklinik</name>
      <address>
        <city>Bad Sooden-Allendorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Lathan</name>
      <address>
        <city>Dortmund</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Verpoort - Dr. Zeller</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. J.-U. Rüffer</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Fakultät der Universität Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinisches Versorgungszentrum - MOP</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2008</study_first_submitted>
  <study_first_submitted_qc>September 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2008</study_first_posted>
  <last_update_submitted>January 12, 2010</last_update_submitted>
  <last_update_submitted_qc>January 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Armin Engels, Medical Advisor</name_title>
    <organization>Medice Arzneimittel Pütter GmbH &amp; Co KG</organization>
  </responsible_party>
  <keyword>Fatigue, Cancer, Methylphenidate,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylphenidate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

